DCZRX Mutual Fund

DCZRX Mutual Fund

NAV$34.28
See how much of DCZRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$1.4B
Expense Ratio
0.69%
Dividend Yield (Current)
0.52%
Holdings
143
Inception Date
May 2, 2016
Fund Family
Nomura Asset Management Co Ltd
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
SEC 30-Day Yield
PRO

Performance

YTD+11.85%
1 Year+15.00%
3 Year+13.19%
5 Year+6.09%
10 Year+10.23%

Asset Allocation

Stocks: 99.15%
Cash: 0.85%
See how much of DCZRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TVTXTravere Therapeutics Inc1.99%
LGNDLigand Pharmaceuticals, Inc.1.83%
IMX:SGImax Corp1.62%
SUPNSupernus Pharmaceuticals Inc1.62%
FSSFederal Signal Corp1.50%
Top 10 Concentration: 15.49%Report Date: Aug 31, 2026
Download all 143 holdings for DCZRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.52%
Latest Distribution
$2.02
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

DCZRX Mutual Fund Overview

DCZRX Mutual Fund (Nomura Small Cap Core Fund Class R6) is managed by Nomura Asset Management Co Ltd with $1.40B in net assets. DCZRX expense ratio is 0.69%, holding 143 positions across sectors including Health Care, Financials, Industrials. Inception date: 2016-05-02.

DCZRX performance shows a YTD return of 11.85%. The 1-year return is 15.00% and the 5-year return is 6.09%. DCZRX dividend yield stands at 0.52%.

DCZRX top holdings include Travere Therapeutics Inc (2.0%), Ligand Pharmaceuticals, Inc. (1.8%), Imax Corp (1.6%), Supernus Pharmaceuticals Inc (1.6%), Federal Signal Corp (1.5%). Go to all DCZRX holdings, DCZRX sectors, or DCZRX dividends.

DCZRX can be compared against other funds. Use DCZRX overlap to find shared positions, or DCZRX vs another fund for a side-by-side view. DCZRX alternatives are available via the screener, along with tax-loss harvesting opportunities.